BeStock  

Option Care Health OPCH

US equityMarket cap rank #2089Medical Care Facilities
$31.59 −$0.02 (-0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $31.58 -0.03%
Open$31.60
Prev close$31.61
Day range$31.56 – $31.66
Volume2.95M
Market cap$4.73B
P/E (TTM)22.9
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$1.49B+4.1% YoY
Operating profit$89.22M+5.6% YoY
Net profit$57.43M+10.8% YoY
Diluted EPS$0.38+18.8% YoY
Free cash flow$108.05M-17.0% YoY
Operating cash flow$114.73M

Revenue, last 8 quarters

$1.3BDec '24$1.3BMar '25$1.4BJun '25$1.4BSep '25$1.5BDec '25$1.4BMar '26$1.4BJun '26$1.5BSep '26

Net profit, last 8 quarters

$60.1MDec '24$46.7MMar '25$50.5MJun '25$51.8MSep '25$58.5MDec '25$45.3MMar '26$53.9MJun '26$57.4MSep '26

Diluted EPS by quarter

0.35Dec '240.28Mar '250.31Jun '250.32Sep '250.37Dec '250.29Mar '260.35Jun '260.38Sep '26

Free cash flow by quarter

$25.8MDec '24$-16.6MMar '25$81.2MJun '25$130.2MSep '25$22.2MDec '25$-21.2MMar '26$172.5MJun '26$108.0MSep '26

Annual revenue

$3.0BFY20$3.4BFY21$3.9BFY22$4.3BFY23$5.0BFY24$5.6BFY25

Profitability & balance sheet

Gross margin19.1%
Operating margin5.9%
Net margin3.7%
Return on equity16.0%
Return on assets6.2%
Return on invested capital9.7%
Current ratio1.54
Liabilities / assets61.9%
Cash & investments$299.09M
Total debt$1.24B
Net cash (debt)-$940.99M
Free cash flow / sales4.9%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Infusion Services$1.47B 98.2%
  • Other revenue$26.77M 1.8%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $1.49B $1.44B $1.35B $5.65B $1.47B
Total Operating Revenue $1.49B $1.44B $1.35B $5.65B $1.47B
Cost of Revenue $1.21B $1.18B $1.09B $4.56B $1.18B
Gross Profit $284.97M $267.25M $262.01M $1.09B $282.90M
Operating Expense $195.76M $182.11M $189.47M $749.99M $191.40M
Selling and Admin Expenses $177.64M $164.66M $174.56M $682.45M $172.14M
Depreciation & Amortization & Depletion $18.12M $17.45M $14.91M $67.54M $19.26M
-Depreciation & Amortization $18.12M $17.45M $14.91M $67.54M $19.26M
Operating Profit $89.22M $85.14M $72.55M $337.91M $91.50M
Net Non-Operating Interest Income (Expense) -$12.88M -$14.02M -$13.30M -$54.56M -$12.73M
Non-Operating Interest Expense $12.88M $14.02M $13.30M $54.56M $12.73M
Other Income (Expense) $2.56M $2.87M $1.76M -$448,000.00 $2.75M
Earnings from Equity Interest $1.52M $1.70M $1.69M $7.41M $2.11M
Other Non-Operating Income (Expenses) $1.04M $1.16M $73,000.00 -$7.86M $640,000.00
Pretax Profit $78.90M $73.99M $61.00M $282.90M $81.52M
Tax $21.47M $20.07M $15.66M $75.32M $23.01M
Net Profit $57.43M $53.91M $45.34M $207.59M $58.50M
Profit from Continuing Operations $57.43M $53.91M $45.34M $207.59M $58.50M
Net Income to Parent Company $57.43M $53.91M $45.34M $207.59M $58.50M
Net Income to Common Stockholders $57.43M $53.91M $45.34M $207.59M $58.50M
Basic EPS $0.38 $0.35 $0.29 $1.28 $0.37
Diluted EPS $0.38 $0.35 $0.29 $1.27 $0.37

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $3.48B $3.38B $3.38B $3.46B $3.46B
Total Current Assets $1.31B $1.20B $1.20B $1.26B $1.26B
Cash and Cash Equivalents & Short-Term Investments $299.09M $193.77M $177.32M $232.62M $232.62M
-Cash and Cash Equivalents $299.09M $193.77M $177.32M $232.62M $232.62M
Receivables $535.27M $549.21M $516.44M $473.57M $473.57M
-Accounts Receivable $505.57M $356.61M $516.44M $473.57M $473.57M
-Other Receivables $29.70M $192.60M – – –
Inventory $408.05M $399.61M $415.69M $471.15M $471.15M
Other Current Assets $69.69M $58.01M $85.66M $87.63M $87.63M
Total Non-Current Assets $2.16B $2.18B $2.18B $2.19B $2.19B
Net PPE $224.16M $229.76M $229.71M $230.49M $230.49M
-Gross PPE $380.48M $377.23M $372.42M $360.30M $360.30M
-Accumulated Depreciation -$156.32M -$147.47M -$142.70M -$129.81M -$129.81M
Goodwill and Other Intangible Assets $1.89B $1.90B $1.91B $1.92B $1.92B
-Goodwill $1.61B $1.61B $1.61B $1.61B $1.61B
-Other Intangible Assets $281.37M $290.64M $299.91M $309.18M $309.18M
Other Non-Current Assets $51.90M $51.04M $48.63M $44.39M $44.39M
Total Liabilities $2.15B $2.12B $2.03B $2.13B $2.13B
Total Current Liabilities $850.53M $819.48M $729.75M $829.35M $829.35M
Payables $670.68M $639.77M $545.02M $639.83M $639.83M
-Accounts Payable $670.68M $639.77M $545.02M $639.83M $639.83M
Current Accrued Expenses $88.28M $83.62M $104.48M $88.33M $88.33M
Short-Term Debt and Capital Lease Obligation $29.23M $29.87M $30.82M $30.78M $30.78M
-Current Debt $6.78M $6.78M $6.78M $6.78M $6.78M
-Current Capital Lease Obligation $22.45M $23.09M $24.04M $24.00M $24.00M
Total Non-Current Liabilities $1.30B $1.30B $1.30B $1.30B $1.30B
Long Term Debt and Capital Lease Obligation $1.23B $1.24B $1.24B $1.24B $1.24B
-Long Term Debt $1.15B $1.15B $1.15B $1.15B $1.15B
-Long Term Capital Lease Obligation $82.25M $86.17M $86.31M $88.52M $88.52M
Non-Current Deferred Liabilities $65.58M $58.92M $57.89M $56.02M $56.02M
Other Non-Current Liabilities $2.37M $2.27M $2.05M $1.44M $1.44M
Total Equity $1.32B $1.26B $1.35B $1.33B $1.33B
Stockholders' Equity $1.32B $1.26B $1.35B $1.33B $1.33B
Capital Stock $18,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
-Common Stock $18,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.28B $1.27B $1.26B $1.26B $1.26B
Retained Earnings $1.03B $976.18M $922.26M $876.92M $876.92M
Less: Treasury Stock -$987.30M -$987.30M -$835.74M -$818.20M -$818.20M
Gains/Losses Not Affecting Retained Earnings $929,000.00 $2.23M $3.37M $4.11M $4.11M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $114.73M $183.60M -$12.11M $258.45M $35.89M
Net cash flow from continuing operations $114.73M $183.60M -$12.11M $258.45M $35.89M
Net Income from Continuing Operations $57.43M $53.91M $45.34M $207.59M $58.50M
Gain/Loss from Continuing Operations -$1.52M -$1.70M -$1.69M -$2.67M -$2.11M
Depreciation & Depletion & Amortization $18.84M $18.38M $15.66M $70.69M $20.32M
Deferred Tax $6.66M $1.04M $1.87M $8.44M $6.00M
Other Non-Cash Items $6.74M $6.10M $6.25M $30.19M $7.41M
Change in Working Capital $15.75M $96.39M -$89.73M -$99.75M -$65.45M
-Change in Receivables $5.94M $4.93M -$42.87M -$54.59M $837,000.00
-Change in Inventory -$8.44M $16.08M $55.46M -$81.47M -$56.57M
-Change in Prepaid Assets -$4.98M -$11.19M $1.23M $17.76M -$6.94M
-Change in Payables and Accrued Expense $29.99M $93.24M -$98.08M $35.71M $1.31M
-Change in Other Current Liabilities -$6.03M -$5.68M -$5.86M -$24.03M -$5.92M
-Change In Other Working Capital -$733,000.00 -$984,000.00 $382,000.00 $6.88M $1.82M
Net cash flow from investing -$6.68M -$11.68M -$9.32M -$161.08M -$13.65M
Net Cash Flow from Continuing Investing Activities -$6.68M -$11.68M -$9.32M -$161.08M -$13.65M
Net PPE Purchase and Sale -$6.68M -$11.08M -$9.05M -$41.31M -$13.65M
Net Business Purchase and Sale $0.00 $0.00 $0.00 -$117.25M $0.00
Net Other Investing Changes $0.00 -$603,000.00 -$274,000.00 -$2.53M $0.00
Financing Cash Flow -$2.72M -$155.47M -$33.87M -$277.31M -$99.44M
Net Cash Flow from Continuing Financing Activities -$2.72M -$155.47M -$33.87M -$277.31M -$99.44M
Net Issuance Payments Of Debt -$1.70M -$1.70M -$1.70M $44.28M -$181.94M
Net Common Stock Issuance $0.00 -$153.01M -$17.54M -$309.95M -$95.06M
Proceeds from Stock Option Exercised -$994,000.00 -$1.69M -$12.60M -$10.60M -$2.68M
Net Other Financing Charges -$30,000.00 $922,000.00 -$2.04M -$1.04M $180.24M
Ending Cash Balance $299.09M $193.77M $177.32M $232.62M $232.62M
Net Change in Cash $105.33M $16.45M -$55.30M -$179.94M -$77.20M
Beginning Cash Balance $193.77M $177.32M $232.62M $412.57M $309.82M
Free Cash Flow $108.05M $172.52M -$21.16M $217.14M $22.25M

Discussion

No comments yet — be the first to weigh in on OPCH.

Sign in to join the discussion.

Scroll to Top